Singapore-based biomedical start-up AEvice Health beat out over 680 start-ups from 18 countries in a pitching competition organised by Slush, Channel NewsAsia and Techventure as part of the Singapore Week of Innovation and TeCHnology (SWITCH) 2016.
AEvice Health is a biomedical startup that creates an asthma monitoring device (BioAsthma) through its proprietary algorithm. A spin-off from Nanyang Technological University, AEvice Health was founded in 2016 by Professor Ser Wee (Co-Founder), Adrian Ang (Co-Founder), and Edmund Shao (Market Strategist and Co – Founder).
BioAsthma is a patented wearable device that can continuously monitor the condition of asthma patients. It monitors asthma symptoms as well as the severity of asthma.
The proprietary technology was invented by Professor Ser Wee from the School of EEE in Nanyang Technological University back in 2009, and was later successfully patented in 2015. Professor Ser Wee is also the Technical Consultant for AEvice Health.
Adrian Ang graduated from Nanyang Technological University in 2014 with a Bachelor's degree in Electrical & Electronics Engineering. He was previously a FYP student under Professor Ser Wee and has carried out a year-long research in digital processing algorithm under his supervision.
Edmund Shao studied Chemistry and Biological Chemistry with a Minor in Entrepreneurship at Nanyang Technology University. He joined the Ser-Ang team as a co-founder and serves as the business developer for AEvice Health.
From left: Edmund Shao, Market Strategist & Co-Founder , Associate Professor Ser Wee, Co-Founder, Adrian Ang, CEO & Co-Founder [Image: AEvice Health]
Published on: 7-Nov-2016